← SynDRA
GW842166X
SynDRA canonical compound SYN0007083 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Primary target(s) | CNR2 |
| Mechanism of action | cannabinoid receptor agonist |
All known targets
Mechanisms of action (all sources)
- CNR2 AGONIST
- Cannabinoid CB2 receptor agonist
- cannabinoid receptor agonist
Cross-references
Synonyms
- Gw-842,166x
- GW-842166
- GW-842166X
- GW842166
- 842166X
- UNII-VL1I6P2DZ8
- VL1I6P2DZ8
- GW 842166
- CHEMBL225411
- 2-((2,4-dichlorophenyl)amino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide
- TWQYWUXBZHPIIV-UHFFFAOYSA-N
- MLS006010287
- C18H17Cl2F3N4O2
- SCHEMBL3015040
- DTXSID60216786
- MolPort-009-019-316
- HMS3656P06
- BCP05306
- ZINC3947932
- BDBM50211843
- s2778
- 2455AH
- AKOS032945128
- DB11903
- BCP9000755
- CS-7768
- SB19546
- API0013938
- GW-842,166X
- NCGC00346697-05
- NCGC00346697-01
- KB-77649
- HY-14167
- GW8-42166X
- compound 35 [PMID: 17477516]
- GW8-42166
- compound 35 (PMID: 17477516)
- RefChem:783290
Look up GW842166X in the interactive SynDRA portal →